|
ZNF670 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.26909999997871E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.00080000029624E-07 |
| Normal-vs-Stage2 |
8.386700E-04 |
| Normal-vs-Stage3 |
2.415300E-03 |
| Normal-vs-Stage4 |
1.300590E-03 |
| Stage1-vs-Stage2 |
8.471600E-01 |
| Stage1-vs-Stage3 |
5.215600E-01 |
| Stage1-vs-Stage4 |
6.865200E-01 |
| Stage2-vs-Stage3 |
7.603800E-01 |
| Stage2-vs-Stage4 |
5.828800E-01 |
| Stage3-vs-Stage4 |
4.751800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.0047000000023E-06 |
| Normal-vs-AfricanAmerican |
1.204900E-04 |
| Normal-vs-Asian |
8.118000E-03 |
| Caucasian-vs-AfricanAmerican |
7.026200E-01 |
| Caucasian-vs-Asian |
5.989600E-01 |
| AfricanAmerican-vs-Asian |
5.011000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.03499999576573E-08 |
| Normal-vs-Female |
9.420900E-03 |
| Male-vs-Female |
6.156800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.426500E-04 |
| Normal-vs-Extreme_Weight |
8.3290000452152E-09 |
| Normal-vs-Obese |
4.808100E-04 |
| Normal-vs-Extreme_Obese |
4.233900E-04 |
| Normal_Weight-vs-Extreme_Weight |
1.882200E-01 |
| Normal_Weight-vs-Obese |
5.258800E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.476000E-01 |
| Extreme_Weight-vs-Obese |
2.274100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.344200E-01 |
| Obese-vs-Extreme_Obese |
1.663210E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.360400E-02 |
| Normal-vs-Age(41-60Yrs) |
1.76818999999551E-05 |
| Normal-vs-Age(61-80Yrs) |
2.89909999995341E-06 |
| Normal-vs-Age(81-100Yrs) |
1.53803999999313E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.358400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.072000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.652470E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.641240E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.815100E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.833800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.21260000046841E-07 |
| Normal-VS-Type2 PRCC |
1.11850000372726E-08 |
| Normal-VS-KIRP CIMP |
4.637600E-01 |
| Normal-VS-Unclassified PRCC |
8.761700E-04 |
| Type1 PRCC-VS-Type2 PRCC |
4.630000E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.325700E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
7.328400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.544700E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.023160E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.338850E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.51019999838908E-08 |
| Normal-vs-N1 |
1.240990E-01 |
| Normal-vs-N2 |
2.803300E-03 |
| N0-vs-N1 |
4.443600E-03 |
| N0-vs-N2 |
2.864400E-01 |
| N1-vs-N2 |
7.923600E-02 |
|
|
